FGF2 and Stroke: Meanwhile, a recent preclinical study of taVNS treatment in rats with post-stroke dysphagia found that it significantly increased the number of swallowing times within 20 s, the expression of vascular endothelial growth factor, and basic fibroblast growth factor.